HIMS
Save the date
Hims & Hers Health just put a pin in the calendar: first-quarter 2026 results land after the close on Monday, May 11, and management will hop on a conference call at 5:00 p.m. ET.
That might sound like a routine corporate calendar invite, but for a stock like HIMS, earnings calls are where the story gets a fresh coat of paint. You’re not just listening for revenue and profit — you’re listening for whether the company is still converting its wellness-meets-telehealth pitch into actual growth.
Why investors will be glued to the call
The big questions are the usual suspects:
- Is revenue still climbing at a healthy clip?
- Are margins improving, or is growth still eating the bill?
- What does management say about demand, customer retention, and the next leg of expansion?
If Hims & Hers comes in hot, the stock can keep wearing its “consumer brand disguised as healthcare” costume with confidence. If the numbers wobble, investors may start asking whether the easy growth phase is fading.
Big picture
This is a schedule notice, not a result. But for shareholders, it’s still the moment the market starts lining up for the main event.